Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ABBV AbbVie	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$232.42 +0.8%		Neutral
ABEO Abeona Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.40 +0.7%	$20.00	Buy
ABVX Abivax	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.72 +1.0%	$142.00	Overweight
ACLS Axcelis Technologies	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.72 +1.9%	$90.00	Neutral ➝ Underperform
ADPT Adaptive Biotechnologies	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sebastian Sandler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.31 +0.9%	$14.00 ➝ $17.00	Overweight
AEIS Advanced Energy Industries	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$179.19 +5.6%	$150.00 ➝ $175.00	Buy
AEIS Advanced Energy Industries	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Ricchiuti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$179.19 +5.6%	$155.00 ➝ $188.00	Buy
AES AES	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.52 +3.2%	$16.00 ➝ $17.00	Positive
AESI Atlas Energy Solutions	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.72 +1.6%	$11.00
AGX Argan	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Drew Chamberlain Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$293.44 +14.6%	$220.00 ➝ $315.00	Neutral ➝ Overweight
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
AGX Argan	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$293.44 +14.6%	$315.00
ALGN Align Technology	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$129.09 +2.6%	$170.00
ALNY Alnylam Pharmaceuticals	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Fye Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$468.18 +1.7%	$475.00 ➝ $473.00	Overweight
AMAT Applied Materials	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$219.24 +4.4%	$180.00 ➝ $215.00	Buy
AMAT Applied Materials	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$219.24 +4.4%	$250.00	Neutral ➝ Buy
AMD Advanced Micro Devices	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$218.96 +1.9%	$275.00
AMD Advanced Micro Devices	Target Set by	KGI Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$218.96 +1.9%	$260.00	Outperform
AMH American Homes 4 Rent	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.69 +0.5%	$39.00 ➝ $38.00	Overweight
AMN AMN Healthcare Services	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tobey Sommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.92 +4.2%	$20.00 ➝ $24.00	Buy
AMT American Tower	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$184.35 -1.3%	$281.00 ➝ $226.00	Buy
ANAB AnaptysBio	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.95 +5.0%	$78.00	Overweight
APA APA	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Hanold Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.58 +2.9%	$23.00 ➝ $24.00	Sector Perform
ARE Alexandria Real Estate Equities	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.54 -0.5%	$88.00 ➝ $79.00	Neutral
AREC American Resources	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.68 +14.7%	$5.00	Buy
ARGX argenex	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$809.69 +1.6%	$800.00 ➝ $880.00	Outperform
ARQQ Arqit Quantum	Target Set by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Buck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.81 +15.0%	$52.00 ➝ $60.00	Buy
ASGN ASGN	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tobey Sommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.91 +1.1%	$75.00 ➝ $65.00	Buy
ASML ASML	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$975.77 +4.2%		Neutral
ASND Ascendis Pharma A/S	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Li Watsek Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.88 +1.6%	$203.00 ➝ $254.00	Overweight
AUGO Aura Minerals	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marcio Farid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.20 +3.4%	$46.60	Buy
AVAH Aveanna Healthcare	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.75 +1.1%	$8.00 ➝ $9.00	Neutral
AVB AvalonBay Communities	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.00 +0.3%	$216.00 ➝ $214.00	In-Line
AVCT Avacta Group	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 71.16 +1.0%	GBX 99	Buy
AVY Avery Dennison	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.37 -0.2%	$204.00 ➝ $203.00	Buy
AZN AstraZeneca	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		£127.44 -0.3%		Overweight
BALL Ball	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.37 +0.6%	$69.00 ➝ $65.00	Buy
BAM Brookfield Asset Management	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Cyprys Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.03 +3.6%	$62.00
BBOX Tritax Big Box REIT	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 145.92 +2.8%	GBX 160	Add
BE Bloom Energy	Reiterated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Amicucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.53 +29.5%		Outperform
BE Bloom Energy	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.53 +29.5%	$43.00 ➝ $105.00	Positive

BITF Bitfarms	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.92 +17.1%	$7.00
BITF Bitfarms	Reiterated by	Macquarie Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.92 +17.1%		Outperform
BLDP Ballard Power Systems	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.50 +6.9%	$2.00 ➝ $3.30	Neutral
BME B&M European Value Retail	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 230.20 +0.1%	GBX 305 ➝ GBX 265	Hold
BMY Bristol Myers Squibb	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Baum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.97 +0.0%		Neutral
BN Brookfield	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.68 +3.8%	$54.00	Overweight
BSTG Biostage	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.45		Buy
BTSG BrightSpring Health Services	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.47 +3.9%	$31.00 ➝ $35.00	Buy
BWA BorgWarner	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris McNally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.46 +0.6%	$42.00 ➝ $50.00	Outperform
BWIN Baldwin Insurance Group	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charlie Lederer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.30 -5.0%	$38.00 ➝ $33.00	Outperform ➝ Market Perform
BX Blackstone	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Voigt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$157.62 +2.5%	$180.00 ➝ $171.00	Market Perform
BX Blackstone	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Allen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$157.62 +2.5%	$185.00 ➝ $170.00	Neutral
BXP BXP	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$70.53 +1.5%	$85.00
BXP BXP	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Dickstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.53 +1.5%	$84.00	Buy
BXP BXP	Initiated by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$70.53 +1.5%	$85.00	Buy
CAMT Camtek	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$117.41 +6.7%	$115.00
CAMT Camtek	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$117.41 +6.7%	$135.00	Neutral ➝ Buy
CAT Caterpillar	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Fisher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$499.42 +1.7%	$450.00 ➝ $506.00	Neutral
CDP COPT Defense Properties	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.60 -0.2%		Buy
CDP COPT Defense Properties	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.60 -0.2%	$33.00
CHMI Cherry Hill Mortgage Investment	Downgraded by	Janney Montgomery Scott Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.31 -0.2%		Buy ➝ Neutral
CIEN Ciena	Upgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$162.52 +4.2%	$185.00	Neutral ➝ Outperform
CIEN Ciena	Target Set by	BNP Paribas Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$162.52 +4.2%	$185.00	Neutral ➝ Outperform
CLDX Celldex Therapeutics	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.84 +0.2%	$25.00	Underweight
CLF Cleveland-Cliffs	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.68 +3.8%	$10.00 ➝ $13.00	Neutral
CLSK Cleanspark	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.71 +2.2%	$22.00 ➝ $26.00	Buy
CLSK Cleanspark	Target Raised by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.71 +2.2%	$20.00 ➝ $30.00	Buy
CLX Clorox	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$120.58 +0.4%	$135.00 ➝ $128.00	Hold
CLYM Climb Bio	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.87 +3.6%	$9.00	Buy
CMC Commercial Metals	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.45 +2.6%	$54.00 ➝ $63.00	Neutral
CME CME Group	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$269.99 -0.5%	$283.00 ➝ $287.00	Market Perform
CME CME Group	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick O'Shaughnessy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$269.99 -0.5%	$307.00	Outperform
COO Cooper Companies	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Miksic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.66 +1.9%	$85.00	Overweight
COP ConocoPhillips	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lloyd Byrne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.61 +1.1%	$129.00 ➝ $120.00	Buy
COP ConocoPhillips	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Hanold Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.61 +1.1%	$113.00 ➝ $118.00	Outperform
COP ConocoPhillips	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$88.61 +1.1%	$115.00 ➝ $117.00	Outperform
COST Costain Group	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 153 +9.1%	GBX 180	Buy
CPT Camden Property Trust	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$101.96 +0.3%	$116.00 ➝ $115.00	In-Line
CPT Camden Property Trust	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$101.96 +0.3%	$112.00 ➝ $111.00	Equal Weight
CRSP CRISPR Therapeutics	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yanan Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.44 -2.2%	$75.00
CRVS Corvus Pharmaceuticals	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.24 +4.5%	$16.00	Overweight
CRWD CrowdStrike	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$503.97 +2.1%	$510.00 ➝ $540.00	Outperform
CSL Carlisle Companies	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Wojs Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$326.84 +0.9%	$440.00 ➝ $385.00	Outperform
CSX CSX	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$35.52 +0.1%		Buy
CTVA Corteva	Target Lowered by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexandra Yates Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.90 +1.7%	$83.00 ➝ $80.00	Buy
CUBE CubeSmart	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Omotayo Okusanya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.81 +1.2%	$45.00	Hold ➝ Buy
CUZ Cousins Properties	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Dickstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.35 -1.0%	$34.00 ➝ $27.00	Buy ➝ Hold
CVLT CommVault Systems	Upgraded by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$174.61 +2.6%	$200.00	Neutral ➝ Overweight
CX Cemex	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Cardona Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.37 +2.4%	$9.00 ➝ $10.00	Buy ➝ Neutral
DAL Delta Air Lines	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sheila Kahyaoglu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.82 +0.6%	$70.00 ➝ $74.00	Buy

DEA Easterly Government Properties	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.00 -1.6%	$20.00
DKNG DraftKings	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Gibas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.28 +1.8%	$30.00
DPZ Domino's Pizza	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$408.69 +0.6%	$455.00
DUOL Duolingo	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Smilek Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$329.56 +1.4%	$515.00 ➝ $465.00	Overweight
DY Dycom Industries	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Fisher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$293.37 +3.2%	$296.00 ➝ $336.00	Buy
EBAY eBay	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Colin Sebastian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$89.09 +0.6%	$89.00 ➝ $100.00	Outperform
EFX Equifax	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Owen Lau Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$228.38 -0.8%	$271.00	Outperform
EL Estee Lauder Companies	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason English Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$92.25 +5.2%	$76.00 ➝ $115.00	Neutral ➝ Buy
EMG Man Group	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 191.55 +1.5%	GBX 175 ➝ GBX 188	Neutral
ENPH Enphase Energy	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.46 +3.5%	$40.00 ➝ $37.00	Neutral
EPRT Essential Properties Realty Trust	Initiated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kai Klose Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.35 +0.5%	$36.00	Buy
EQR Equity Residential	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.88 +0.3%	$72.00 ➝ $71.00	Outperform
ES Eversource Energy	Reiterated by	Janney Montgomery Scott Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Gaugler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.67 -0.9%		Buy ➝ Neutral
ESS Essex Property Trust	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.63 +0.7%	$279.00 ➝ $280.00	Equal Weight
ESS Essex Property Trust	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.63 +0.7%	$283.00 ➝ $279.00	In-Line
ETOR eToro Group	Initiated by	Compass Point Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$39.02 +1.0%	$66.00	Buy
ETSY Etsy	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Smilek Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.05 +1.9%	$60.00 ➝ $65.00	Neutral
EXE Expand Energy	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Silverstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.02 +0.3%	$132.00 ➝ $131.00	Buy
FICO Fair Isaac	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Owen Lau Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,671.31 +0.4%		Outperform ➝ Market Perform
FKWL Franklin Wireless	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.94 +1.9%	$6.00	Buy
FLNC Fluence Energy	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.16 +23.5%	$9.00 ➝ $17.00	Positive
FNLPF Fresnillo	Upgraded by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$34.72 +10.5%		Hold
FORM FormFactor	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.42 +6.0%	$35.00
FSLR First Solar	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$232.56 +2.9%	$222.00 ➝ $273.00	Positive
FSLR First Solar	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$232.56 +2.9%	$240.00 ➝ $264.00	Outperform
GANX Gain Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.94 -1.8%	$8.00	Buy
GEHC GE HealthCare Technologies	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.47 +2.1%	$87.00 ➝ $89.00	Buy
GEHC GE HealthCare Technologies	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Miksic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.47 +2.1%	$86.00	Equal Weight
GEV GE Vernova	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Minervino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$638.65 +5.6%	$736.00 ➝ $740.00	Positive
GFI Gold Fields	Target Set by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.96 +4.8%	$39.00
GFS GlobalFoundries	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$33.78 +2.5%	$35.00	Neutral ➝ Underperform
GHRS GH Research	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.00 +3.3%	$19.00	Buy
GKOS Glaukos	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.46 +2.3%	$118.00 ➝ $104.00	Buy
GM General Motors	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Galliers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.43 +0.1%	$55.00 ➝ $68.00	Outperform
GMRE Global Medical REIT	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.46 +2.1%		Outperform
GMRE Global Medical REIT	Upgraded by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.46 +2.1%	$40.00	Market Perform ➝ Outperform
GMRE Global Medical REIT	Target Set by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Hecht Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.46 +2.1%	$40.00	Market Perform ➝ Market Outperform
GOOGL Alphabet	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Deepak Mathivanan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$241.98 +2.3%	$201.00 ➝ $265.00	Neutral
GPK Graphic Packaging	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.47 -0.3%	$23.00 ➝ $20.00	Hold
HAS Hays	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 58.65 +1.0%		Outperform
HIVE HIVE Digital Technologies	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.53 -1.3%	$10.00	Buy
HIW Highwoods Properties	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.84 -1.5%	$30.00
HLNE Hamilton Lane	Upgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Voigt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$122.12 +3.3%	$150.00	Market Perform ➝ Outperform
HOC Hochschild Mining	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 390 +10.1%	GBX 350 ➝ GBX 465	Buy
HPP Hudson Pacific Properties	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.55 +1.4%	$2.40
HUMA Humacyte	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.69 +8.0%	$7.00 ➝ $6.00	Buy
ICE Intercontinental Exchange	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$158.62 +0.7%	$210.00	Outperform ➝ Strong-Buy
INTC Intel	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$37.12 +2.1%	$34.00	Neutral ➝ Underperform
INTC Intel	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$37.12 +2.1%	$39.00
INVH Invitation Home	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.07 +0.5%	$35.00 ➝ $34.00	Outperform

INVH Invitation Home	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.07 +0.5%	$33.00 ➝ $31.00	Equal Weight
IP International Paper	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.13 +1.0%	$55.00 ➝ $53.00	Buy
IPO IP Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 59.90 +10.5%	GBX 100	Buy
IRTC iRhythm Technologies	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$178.46 +1.3%	$190.00 ➝ $195.00	Buy
ISRG Intuitive Surgical	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Danielle Antalffy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$437.42 +1.8%	$529.00
ISRG Intuitive Surgical	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$437.42 +1.8%	$571.00 ➝ $529.00	Buy
IT Gartner	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Toni Kaplan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$244.82 +2.2%	$307.00
JACK Janus Henderson Sustainable & Impact Core Bond ETF	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.46 +0.7%	$22.00	Buy
JBHT J.B. Hunt Transport Services	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$138.14 +0.8%		Buy
KFRC Kforce	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tobey Sommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.03 +0.8%	$46.00 ➝ $35.00	Hold
KHC Kraft Heinz	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.93 -0.9%	$28.00 ➝ $27.00	Hold
KLAC KLA	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,031.36 +4.9%	$1,050.00
KNSA Kiniksa Pharmaceuticals International	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.96 +0.2%	$38.00 ➝ $44.00	Outperform
KPTI Karyopharm Therapeutics	Upgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.89 +7.1%	$15.00	Neutral ➝ Buy
KRC Kilroy Realty	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Dickstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.23 +1.7%	$33.00 ➝ $45.00	Hold ➝ Buy
KRC Kilroy Realty	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$40.23 +1.7%	$45.00
LBRT Liberty Energy	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eddie Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.16 +0.9%	$14.00 ➝ $12.00	Overweight ➝ Equal Weight
LLOY Lloyds Banking Group	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 83.54 +0.8%	GBX 74	Hold
LRCX Lam Research	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.87 +4.9%	$135.00
MAA Mid-America Apartment Communities	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.03 +0.4%	$154.00 ➝ $153.00	In-Line
MAA Mid-America Apartment Communities	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.03 +0.4%	$156.00 ➝ $157.00	Overweight
MAN ManpowerGroup	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tobey Sommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.89 +2.3%	$48.00 ➝ $44.00	Hold
MELI MercadoLibre	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Friedman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2,201.14 +3.2%	$2,975.00 ➝ $2,900.00	Positive
MGA Magna International	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris McNally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.03 +1.1%	$40.00 ➝ $47.00	In-Line
MGM MGM Resorts International	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Chaiken Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.81 +1.7%	$58.00
MKSI MKS	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.61 +8.5%	$151.00	Overweight
MKSI MKS	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Ricchiuti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.61 +8.5%	$130.00 ➝ $136.00	Buy
MNKD MannKind	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.06 +3.6%	$11.00	Buy
MNMD Mind Medicine (MindMed)	Target Set by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.41 +5.0%	$28.00	Buy
MNPR Monopar Therapeutics	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$93.97 +7.0%	$125.00	Overweight
MOS Mosaic	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.45 +3.6%	$44.00 ➝ $40.00	Buy
MPC Marathon Petroleum	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$183.98 +1.7%	$194.00	Overweight
MQ Marqeta	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.71 -4.8%	$5.00	Neutral ➝ Sell
MRK Merck & Co., Inc.	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geoff Meacham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.82 -0.2%	$84.00 ➝ $95.00	Neutral
MRVL Marvell Technology	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.70 +3.6%	$95.00 ➝ $105.00	Buy
MTDR Matador Resources	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hanwen Chang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.17 +2.4%	$77.00 ➝ $76.00	Overweight
MU Micron Technology	Upgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$188.43 +3.8%	$270.00	Underperform ➝ Outperform
MUR Murphy Oil	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hanwen Chang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.44 +6.2%	$26.00 ➝ $28.00	Equal Weight
MWE M.T.I Wireless Edge	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 40 -7.5%		House Stock
NDAQ Nasdaq	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick O'Shaughnessy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$89.30 +0.5%	$100.00	Outperform
NEE NextEra Energy	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$84.01 +0.8%	$84.00
NFLX Netflix	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Swinburne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,223.29 +0.3%	$1,500.00
NRIX Nurix Therapeutics	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.56 -2.0%	$22.00
NSC Norfolk Southern	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$289.56 +0.4%		Neutral
NTSK Netskope	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$25.00	Buy
NTSK Netskope	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.88 +5.2%		Outperform
NTSK Netskope	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Essex Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$26.00	Overweight
NTSK Netskope	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.88 +5.2%	$25.00	Outperform
NTSK Netskope	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Heath Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$27.00	Overweight
NTSK Netskope	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$27.00	Buy

NTSK Netskope	Initiated by	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.88 +5.2%		Buy
NTSK Netskope	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.88 +5.2%	$27.00
NTSK Netskope	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ittai Kidron Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$28.00	Outperform
NTSK Netskope	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Nowinski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$28.00	Overweight
NTSK Netskope	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$28.00	Overweight
NTSK Netskope	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shaul Eyal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$30.00	Buy
NTSK Netskope	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meta Marshall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$27.00	Overweight
NTSK Netskope	Target Set by	Independent Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.88 +5.2%	$27.00
NTSK Netskope	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$26.00	Outperform
NTSK Netskope	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.88 +5.2%		Outperform
NTSK Netskope	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$26.00	Outperform
NTSK Netskope	Initiated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.88 +5.2%	$27.00	Mkt Outperform
NTSK Netskope	Initiated by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trevor Walsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.88 +5.2%	$27.00	Market Outperform
NTST NETSTREIT	Initiated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kai Klose Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.37 +0.9%	$22.00	Buy
NUE Nucor	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.98 +3.2%	$165.00 ➝ $172.00	Overweight
NUVB Nuvation Bio	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.65 -2.5%	$6.00	Outperform
NVDA NVIDIA	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$188.61 +3.0%	$205.00 ➝ $225.00	Outperform
NXR Norcros	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 282.40 +3.8%	GBX 350 ➝ GBX 410	Buy
NXT Nextracker	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.76 +3.6%	$76.00 ➝ $100.00	Positive
OI O-I Glass	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.61 -0.2%	$21.00 ➝ $17.00	Buy
OMF OneMain	Target Lowered by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Scharf Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.24 +2.1%	$65.00 ➝ $63.00	Market Outperform
OMF OneMain	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$53.24 +2.1%		Outperform
ONTO Onto Innovation	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.52 +8.4%	$120.00
ORCL Oracle	Target Set by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$307.82 +5.1%	$345.00 ➝ $355.00	Outperform
ORKA Oruka Therapeutics	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.96 +1.9%	$48.00	Overweight
OXIG Oxford Instruments	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,826.76 -8.0%	GBX 2,600	Buy
OXIG Oxford Instruments	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,826.76 -8.0%	GBX 2,400	Buy
PANW Palo Alto Networks	Upgraded by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.38 +1.8%		Neutral ➝ Buy
PANW Palo Alto Networks	Target Set by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.38 +1.8%	$248.00	Neutral ➝ Buy
PCH Potlatch	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.98 +0.6%	$52.00 ➝ $51.00	Buy
PERI Perion Network	Target Set by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.86 +7.1%	$14.00	Buy
PHNX Phoenix Group	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 668.29 +0.4%	GBX 850 ➝ GBX 852	Buy
PJT PJT Partners	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$172.22 +0.7%	$180.00
PKG Packaging Corporation of America	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$209.20 +1.2%	$262.00 ➝ $264.00	Buy
PLUG Plug Power	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.93 +14.8%	$1.80 ➝ $3.50	Neutral
PRGS Progress Software	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.43 +4.0%	$57.00	Neutral ➝ Buy
PRU Prudential	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,015.50 +0.8%	GBX 1,200 ➝ GBX 1,275	Overweight
PSA Public Storage	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$297.11 +0.9%		Hold ➝ Buy
PSA Public Storage	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$297.11 +0.9%	$325.00	Hold ➝ Buy
PSKY Paramount Skydance	Initiated by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Bonner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.37 +2.2%	$17.00	Hold
PTEN Patterson-UTI Energy	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eddie Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.57 +3.6%	$7.00 ➝ $6.00	Overweight ➝ Equal Weight
PTGX Protagonist Therapeutics	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$85.03 -2.3%		Outperform
PTGX Protagonist Therapeutics	Target Set by	Johnson Rice Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$85.03 -2.3%	$112.00
PTLO Portillo's	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andy Barish Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.92 -1.4%	$10.00 ➝ $6.00	Buy ➝ Hold
PUMP ProPetro	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eddie Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.05 +0.3%	$6.00 ➝ $5.00	Overweight ➝ Equal Weight
PYPL PayPal	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.81 -1.5%	$70.00	Neutral ➝ Sell
QLT Quilter	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 180.70 +3.4%	GBX 182 ➝ GBX 186	Overweight
RAPT Rapt Therapeutics	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.18 -6.0%	$35.00	Equal Weight ➝ Overweight
RCUS Arcus Biosciences	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.68 +7.4%		Buy
RGP Resources Connection	Reiterated by	Noble Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.48 -1.4%		Outperform
RHI Robert Half	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tobey Sommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.07 +2.3%	$55.00 ➝ $50.00	Buy
RKT Rocket Companies	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.40 +0.0%		Buy
RMD ResMed	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nathan Treybeck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$274.59 +1.0%	$280.00	Equal Weight
RNWH Renew	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 945 +2.8%	GBX 1,350	Buy
RNWH Renew	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 945 +2.8%	GBX 1,300	Buy
RNWH Renew	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 945 +2.8%	GBX 1,200	Buy
ROST Ross Stores	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$153.91 +4.2%		Buy
RS Reliance	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bennett Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$277.28 +1.9%	$350.00 ➝ $345.00	Overweight
RUN Sunrun	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.43 +8.6%	$13.00 ➝ $23.00	Positive
SAIA Saia	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$300.49 +2.1%		Buy
SAUHY Straumann	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.65 -0.8%		Neutral
SCI Service Corporation International	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.84 +2.5%	$88.00 ➝ $95.00	Buy
SCT Softcat	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,582.25 +0.7%	GBX 1,950	Buy
SEDG SolarEdge Technologies	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.31 +6.4%	$25.00 ➝ $40.00	Neutral
SEI Solaris Energy Infrastructure	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.20 +9.4%		Buy
SERV Serve Robotics	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.92 +6.9%		Outperform
SERV Serve Robotics	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.92 +6.9%	$26.00
SFM Sprouts Farmers Market	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$108.75 +5.9%	$176.00 ➝ $148.00	Sector Perform ➝ Outperform
SGHC Super Group (SGHC)	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Hickey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.70 +5.5%	$18.00	Buy
SLG SL Green Realty	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Dickstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.84 +1.2%	$57.00 ➝ $63.00	Neutral ➝ Buy
SLG SL Green Realty	Initiated by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Floris Van Dijkum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.84 +1.2%	$63.00	Neutral
SLGN Silgan	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.01 -0.3%	$67.00 ➝ $62.00	Buy
SNDK Sandisk	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.92 +12.0%		Buy
SNDK Sandisk	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.92 +12.0%	$50.00 ➝ $115.00	Equal Weight
SON Sonoco Products	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.96 +0.9%	$58.00 ➝ $57.00	Buy
SPA 1Spatial	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 52.25 -4.8%	GBX 95	Buy
SR Spire	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Appicelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.25 +1.1%	$80.00 ➝ $95.00	Buy
SSPG SSP Group	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 163.50 +2.1%	GBX 330 ➝ GBX 310	Buy
STEM Stem	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.65 +8.7%	$12.00 ➝ $21.00	Neutral
STJ St. James's Place	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,344.50 +2.1%	GBX 1,550 ➝ GBX 1,600	Overweight
STLD Steel Dynamics	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$146.20 +3.5%	$150.00 ➝ $160.00	Neutral
STX Seagate Technology	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$218.02 +1.7%	$160.00 ➝ $240.00	Equal Weight
STX Seagate Technology	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Amit Daryanani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$218.02 +1.7%	$160.00 ➝ $330.00	Outperform
SVT Severn Trent	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,661 +0.1%	GBX 2,850	Sector perform
SW Smurfit Westrock	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.50 +2.6%	$54.00 ➝ $55.00	Buy
SYK Stryker	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$370.27 +1.6%	$408.00
SYK Stryker	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$370.27 +1.6%	$407.00 ➝ $408.00	Buy
TER Teradyne	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$138.28 +4.7%	$119.00
TFII TFI International	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$88.71 +2.5%		Buy
TGT Target	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$87.62 +2.4%	$108.00
TMDX TransMedics Group	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Young Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.00 +4.4%	$145.00	Buy
TRU TransUnion	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rayna Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.79 +0.1%	$93.00	Outperform
TSLA Tesla	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris McNally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$425.74 +3.0%	$235.00 ➝ $300.00	In-Line
TSLA Tesla	Target Set by	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$425.74 +3.0%	$520.00
TSLA Tesla	Initiated by	Melius Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$425.74 +3.0%	$520.00	Buy
TVRD Tvardi Therapeutics	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.56 -84.2%		Overweight ➝ Neutral
TVRD Tvardi Therapeutics	Downgraded by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Seedhouse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.56 -84.2%		Overweight ➝ Neutral
TVRD Tvardi Therapeutics	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.56 -84.2%	$61.00	Overweight
TXN Texas Instruments	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$174.82 +1.8%	$190.00	Neutral ➝ Underperform
UDR United Dominion Realty Trust	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.02 +0.9%	$42.00 ➝ $41.00	Overweight
UDR United Dominion Realty Trust	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.02 +0.9%	$45.00 ➝ $44.00	Outperform
UNP Union Pacific	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$226.34 +0.4%		Buy
VNO Vornado Realty Trust	Initiated by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$38.77 +2.1%	$48.00	Buy
WDC Western Digital	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$117.69 +2.0%	$95.00 ➝ $150.00	Overweight
WDC Western Digital	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$117.69 +2.0%		Buy
WEC WEC Energy Group	Upgraded by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$115.05 -0.1%		Neutral ➝ Buy
WEN Wendy's	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.67 -0.5%	$9.00
WLK Westlake	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Osterland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.55 +2.5%	$94.00 ➝ $90.00	Buy
WY Weyerhaeuser	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.98 +0.2%	$29.00 ➝ $27.00	Hold
XOM Exxon Mobil	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Silverstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$111.52 +0.7%	$143.00 ➝ $145.00	Buy
XPO XPO	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.28 +1.5%		Buy
YASKY Yaskawa Electric	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$53.20 +2.8%		Buy
YELP Yelp	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shweta Khajuria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.26 +9.9%	$37.00 ➝ $45.00	In-Line ➝ Outperform
ZBH Zimmer Biomet	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$96.16 +1.5%	$118.00 ➝ $122.00	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:25 AM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings